JRC Publications Repository

JRC Publications Repository >

Browsing by Author MORGENSTERN Alfred

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 118 to 134 of 134
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2013Targeted alpha therapy of glioblastoma multiforme with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOCIARA Henryk; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2013Targeted alpha therapy of glioblastoma multiforme: initial clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2011Targeted alpha therapy with 213BiMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2010Targeted Alpha-Radionuclide Therapy of Functionally Critical Located Gliomas with 213Bismuth-DOTA-[Thi8,Met(O2)11]-Substance P - A Pilot TrialCORDIER D.; FORRER F.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GOOD S.; MÜLLER-BRAND J.; MÄCKE H.; REUBI Jean-Claude; MERLO A.Articles in Journals
2006Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral ProteinsDADACHOVA E.; PATEL Martil; TOUSSI S.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; BRECHBIEL M.; GORNY M.k.; ZOLLA-PAZNER S.; CASADEVALL A.; GOLDSTEIN H.Articles in Journals
2013Targeting aberrant DNA double strand break repair in triple negative breast cancer with alpha particle emitter radiolabeled anti-EGFR antibodySONG H.; HOBBS Robert F.; SHAO Chunbo; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; DEWEESE Tl; SGOUROS G.; HEDAYATI MohammadArticles in Journals
2012Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosisESSLER M.; GAERTNER F. C.; NEFF Frauke; BLECHERT B.; SENEKOWITSCH-SCHMIDTKE R.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SEIDL C.Articles in Journals
2009Therapeutic efficacy of intravesical -radioimmunotherapy with Bi-213-anti-EGFR-MAb in a human bladder cancer nude mouse modelPFOST B.; SEIDL C.; AUTENRIETH M.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2013TiO2 nanoparticles as carries of 225Ac/213Bi in vivo generatorsLESZCZUK Edyta; PIOTROWSKA A; BILEWICZ Aleksander; MORGENSTERN Alfred; BRUCHERTSEIFER FrankContributions to Conferences
2013TiO2 nanoparticles as carries of 225Ac/213Bi in vivo generatorLESZCZUK Edyta; PIOTROWSKA A; BILEWICZ Aleksander; MORGENSTERN Alfred; BRUCHERTSEIFER FrankContributions to Conferences
2012Towards developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigensBRYAN R. A.; GUIMARAES A.j.; HOPCRAFT S.; JIANG Z.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DEL POETA M.; TOTOSANTUCCI A.; CASSONE A.; NOSANCHUK J.d., et alArticles in Journals
2014Treatment of bladder cancer with Bi-213-anti-EGFR-MAb – a pilot studySCHEIDHAUER Klemens; SEIDL C.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; AUTENRIETH Michael; KURTZ F; ESSLER M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2012Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent miceJIANG Z.; BRYAN R. A.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.Articles in Journals
2013Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA in combination with cisplatin and gemcitabineBRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; ONYEDIKA C; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SELLERS R.; EPSTEIN A, et alContributions to Conferences
2009Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor CellsDRECOLL E.; GAERTNER F. C.; MIEDERER M.; BLECHERT B.; VALLON M.; MÜLLER J.; ALKE A.; SEIDL C.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred, et alArticles in Journals
2011Unprecedented Incorporation of alpha-Emitter Radioisotope 213Bi into Porphyrin Chelates with Reference to a Daughter Isotope Mediated Assistance MechanismLE GAC Stephane; NAJJARI Btissam; MOTREFF Nicolas; REMAUD-LE SAEC Patricia; FAIVRE-CHAUVET A; DIMANCHE-BOITREL M; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; LACHKAR M; BOITREL BernardArticles in Journals
2010Zur Elektronenstruktur hochsymmetrischer Verbindungen der f-Elemente 44 [1]. Erstmalige parametrische Analyse des Absorptionsspektrums einer Molekülverbindung des trivalenten Urans: Tris[hydrotris(1-pyrazolyl)borato]uran(III) Electronic Structures of Highly Symmetrical Compounds of f Elements 44 [1]. First Parametric Analysis of the Absorption Spectrum of a Molecular Compound of Tervalent Uranium: Tris[hydrotris(1-pyrazolyl)borato]uranium(III)APOSTOLIDIS Christos; MORGENSTERN Alfred; REBIZANT J.; KANELLAKOPOULOS Basil; WALTER Olaf; POWIETZKA Bernhard; KARBOWIAK Miroslav; REDDMANN H.; AMBERGER H.-D.Articles in Journals
Showing results 118 to 134 of 134

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top